The Brookbush Institute continues to enhance education with new articles, new courses, a modern glossary, an AI Tutor, ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...

"Fast Track designation is an important regulatory milestone for PBGENE-DMD and reflects the significant unmet need in DMD," said Michael Amoroso, Chief Executive Officer of Precision BioSciences. "We ...

Sedona inpatient program educates on iloperidone side effects, anticholinergic burden, and holistic alternatives for ...

Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS treatments into clinics for heart failure and Parkinsons ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

Just in time for Heart Month, the laboratory of University de Montréal medical professor and CHU Sainte-Justine researcher Rubén Marín‑Juez has unveiled the first comprehensive atlas of coronary ...

Background Patients with heart failure (HF) frequently suffer from undetected declines in cardiorespiratory fitness (CRF), which significantly increases their risk of poor outcomes. However, current ...

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives.

In this study, the authors identify EOLA1 as a novel mitochondrial protein required for mitochondrial translation and normal cardiac function. The characterization of the molecular role of EOLA1 is ...

More than 800,000 Americans will have a heart attack this year. Fortunately, most will survive the traumatic event — but many will emerge with hearts damaged beyond repair. “Many tissues in your body, ...

Phosphorylation of the myosin-heavy chain associated regulatory light chain (RLC) by cardiac myosin light chain kinase (cMLCK) is a key regulatory pathway to modulate contractility in the heart.